Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Pifzer

Sanofi reception

Sanofi and Translate Bio eye launch of phase 1/2 COVID-19 vaccine study

Preclinical data for mRNA-based vaccine supports clinical development

Harnessing Technology to Improve Health and Healthcare

Steven Collens, Chief Executive Officer at MATTER, discusses his professional journey, his work to empower digital health technology startups, and how MATTER is helping businesses define their challenges, identify solutions, and innovate...

Impetus Digital

Telemedicine and the Digitization of Medicine post COVID-19

Samantha Lippolis, Telehealth Advisor at Sam I am Innovates; Dr. Daniel Fagbuyi, CEO of Erudition; Dr. Brian Block, Health Care Consultant at Brian Block Consulting; Mindy Klowden, Director of Strategic Initiatives at the Colorado Behavioral Healthcare...

Impetus Digital

- PMLiVE

Biopharma industry encouraged by EMA’s COVID-19 transparency measures

IFPMA and EFPIA welcome new transparency measures for potential treatments and vaccines

- PMLiVE

Looking after the mental wellbeing of the Porterhouse family

At Porterhouse Medical Group, as a busy insight-led healthcare communications agency group, we recognise the importance of mental health and that mental health issues are a normal part of life...

Porterhouse Medical Group

OLED Medical Technology Saving Patient’s Sight During COVID-19 Pandemic

North East MedTech company secures investment agreement with Japanese tech giant

Onyx Health

- PMLiVE

Celltrion launches phase 3 trial of COVID-19 mAb

Investigational monoclonal antibody will be tested as a preventative treatment

- PMLiVE

Eli Lilly’s COVID-19 antibody trial paused due to safety issue

Company has voluntarily paused study amid safety review

- PMLiVE

Relief Therapeutics’ COVID-19 drug shows positive results ahead of trial readout

Patients treated in intensive care met survival threshold in open-label study

- PMLiVE

J&J halts COVID-19 vaccine study after unexplained participant illness

Company convened data and safety monitoring board to review event

- PMLiVE

Regeneron seeks US emergency use authorisation for COVID-19 antibody cocktail

If approved, the US government will make initial doses available at no cost

- PMLiVE

UK scientists begin testing BCG vaccine for severe COVID-19 protection

Researchers believe shot could help to protect against severe COVID-19

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links